Abstract
To assess pulmonary functions using spirometry in children with moderate-persistent asthma and gastroesophageal reflux disease (GERD) before and 12 months after anti-GERD treatment. Sixty-two children (6–11 years old) with moderate-persistent asthma and no risk factors underwent extended esophageal pH monitoring. Forty-four children had abnormal studies suggesting GERD. Of these 44 children, 32 underwent medical (group A) and 12 underwent surgical (group B) anti-GERD treatment respectively. The remaining 18 patients with normal pH probe studies served as controls (group C). Spirometry was performed before and 1 year after anti-GERD treatment. Overall, despite clinical improvement in their asthma, there was no significant change in the pretreatment and posttreatment forced expiratory volume in 1 second (FEV1) or forced expiratory flow, midexpiratory phase (FEF25%–75%) in any group. One year of anti-GERD treatment in children with moderate-persistent asthma and GERD does not result in consistent improvement...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
